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Abstract 1 
2 
Purpose. To characterize the physiological changes in 25-hydroxyvitamin D [25(OH)D] and 1,25-dihydroxivitamin 3 
D [1,25(OH)2D] throughout pregnancy. Methods. Prospective cohort of 229 apparently healthy pregnant women 4 
followed at 5th-13th, 20th-26th and 30th-36th gestational weeks. 25(OH)D and 1,25(OH)2D concentrations were 5 
measured by LC-MS/MS. Statistical analyses included longitudinal linear mixed-effects models adjusted for parity, 6 
season, education, self-reported skin color and pre-pregnancy BMI. Vitamin D status was defined based on 7 
25(OH)D concentrations according to the Endocrine Society Practice Guideline and Institute of Medicine (IOM) for 8 
adults. Results. The prevalence of 25(OH)D <75 nmol/L was 70.4%, 41.0% and 33.9%; the prevalence of 25(OH)D 9 
<50 nmol/L was 16.1%, 11.2% and 10.2%; and the prevalence of 25(OH)D <30 nmol/L was 2%, 0% and 0.6%, at 10 
the first, second and third trimester, respectively. Unadjusted analysis showed an increase in 25(OH)D (β=0.869; 11 
95%CI, 0.723-1.014; P<0.001) and 1,25(OH)2D  (β=3.878; 95%CI, 3.136-4.620; P<0.001) throughout pregnancy. 12 
Multiple adjusted analyses showed that women who started the study in winter (P<0.001), spring (P<0.001) or 13 
autumn (P=0.028) presented a longitudinal increase in 25(OH)D concentrations, while women that started during 14 
summer did not. Increase of 1,25(OH)2D concentrations over time in women with insufficient vitamin D (50-75 15 
nmol/L) at baseline was higher compared to women with sufficient vitamin D (≥75 nmol/L) (P=0.006). Conclusions. 16 
The prevalence of vitamin D inadequacy varied significantly according to the adopted criteria. There was a seasonal 17 
variation of 25(OH)D during pregnancy. The women with insufficient vitamin D status present greater longitudinal 18 
increases in the concentrations of 1,25(OH)2D in comparison to women with sufficiency. 19 
20 
Keyword: Vitamin D; pregnancy; micronutrients; cohort; tropical country; seasons. 21 
22 
23 
24 
25 
26 
27 
28 
29 
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Introduction 30 
Vitamin D deficiency or insufficiency is considered to be a global public health problem [1-2] with an 31 
estimated 1 billion people affected worldwide [3]. Pregnant women have been identified as a high-risk group for 32 
vitamin D deficiency [4], even in sunny regions [5-7]. Vitamin D is a pro-hormone with an important role in 33 
maintaining bone health [3]. Low vitamin D status during pregnancy has been associated with non-skeletal maternal 34 
and child outcomes such as preeclampsia, gestational diabetes mellitus, preterm birth, small for gestational age, and 35 
low birth weight [5,8]. These pregnancy complications continue to be important public health problems in Brazil [9-36 
12]. 37 
Vitamin D can be obtained from foods and supplements, but the main source is sun exposure enabling 38 
synthesis in the skin induced by ultraviolet B radiation (wavelengths 290–315 nm) [3,13-14]. It is known that 39 
maternal vitamin D concentrations can be influenced by skin pigmentation, age, season, sunscreen use, latitude, 40 
physical activity, obesity status, atmospheric pollution, blood concentrations of parathyroid hormone, calcium, and 41 
phosphate [3,5,15-18].  42 
Vitamin D from the skin and the diet is converted in the liver into 25-hydroxyvitamin D [25(OH)D] which 43 
is then metabolized in the kidneys to its active form, 1,25-dihydroxyvitamin D [1,25(OH)2D] by the 1α-hydroxylase 44 
enzyme. Due to the short biological half-life of 1,25(OH)2D, vitamin D status is usually determined  by measuring 45 
the 25(OH)D concentrations, which is the major circulating form of vitamin D in the blood [3,13-14].  46 
During pregnancy there are physiological changes in 1,25(OH)2D concentrations to ensure sufficient 47 
calcium required for fetal bone mineralization [19]. A gradual increase on plasma 1,25(OH)2D concentrations during 48 
pregnancy and a modest contribution from synthesis in both the kidney and placenta have been reported [19-20]. 49 
However, the profile of the longitudinal changes in 25(OH)D concentrations as well the relationship between 50 
1,25(OH)2D and 25(OH)D throughout pregnancy remains unclear [20-22].   51 
 Despite these physiological changes in pregnant women the criteria for defining vitamin D deficiency and 52 
insufficiency are the same as for the general adult population and cutoff values remain controversial [4,14]. The 53 
Institute of Medicine (IOM) [14] recommends that at least 30 nmol/L of 25(OH)D is necessary to protect against 54 
rickets in children and osteoporosis in adults and that concentrations of  ≥ 50 nmol/L corresponds to the level which 55 
meets the requirements of 97.5% of the population to obtain the recommended daily allowance of  600 IU/day [14]. 56 
The Endocrine Society Practice Guidelines [4] states that 50 nmol/L is required for optimal bone health but 57 
recommends concentrations ≥75 nmol/L for non-skeletal health benefits associated with vitamin D [4].  58 
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Few prospective studies have investigated changes in 25(OH)D and 1,25(OH)2D concentrations over time 59 
during pregnancy [21-22]. Further, there are no studies in healthy pregnant Brazilian women. To the best of our 60 
knowledge, the association between 25(OH)D status in the first trimester of pregnancy and the change in 61 
1,25(OH)2D concentrations throughout gestation has not been assessed by previous studies. Therefore, considering 62 
the importance of adequate vitamin D status during pregnancy for positive gestational outcomes, the aim of this 63 
study was to estimate the prevalence of vitamin D inadequacy and to characterize the physiological changes in 64 
25(OH)D and 1,25(OH)2D concentrations among healthy pregnancies. 65 
 66 
Methods  67 
Design and study participants 68 
 This is a prospective cohort study conducted at a public health care center in Rio de Janeiro, Brazil. The 69 
recruitment was done between November 2009 and October 2011, and 299 women who met the following eligibility 70 
criteria agreed to participate in the study: being between 5th-13th weeks of gestation, free from chronic (except 71 
obesity) and infectious diseases, aged between 20 and 40 years, presenting a singleton pregnancy, residing in the 72 
study catchment area, and intending to continue prenatal care in the public health centre. The cohort comprised 229 73 
apparently healthy pregnant women after exclusions, including: confirmed pre-gestational diagnosis of chronic non-74 
communicable diseases (except obesity) (n=12), diagnosis of infectious or parasitic diseases (n=9), twin pregnancies 75 
(n=4), missed baseline evaluation data (n=20) or miscarriage (n=25). We further excluded women with insufficient 76 
volume to measure plasma 25(OH)D (n=30) or 1,25(OH)2D (n=23) at the first trimester. Our sample comprised 199 77 
and 178 women at the first trimester with available data on 25(OH)D and 1,25(OH)2D concentrations, respectively. 78 
The women were followed at the first [(5-13 weeks (baseline)], second (20-26 weeks), and third trimesters (30-36 79 
weeks) of pregnancy (Online Resource Fig. 1).   80 
 81 
Biochemical analyses 82 
 A trained professional collected blood samples between 6:50 and 7:50 am into vacutainer tubes at each 83 
follow-up visit after a 12-hour fasting period. The samples were centrifuged (5,000 rpm for 5 minutes). The plasma 84 
was separated and prepared from blood collected into tubes containing EDTA, and stored at -80°C for subsequent 85 
analysis.  86 
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Plasma concentrations of 25(OH)D and 1,25(OH)2D were measured by liquid chromatography-tandem 87 
mass spectrometry (LC-MS/MS) using the LC Thermo Cohesive System coupled to Thermo Quantum Ultra Mass 88 
Spectrometer (Thermo Fisher; San Jose, CA, USA). The analyses were performed by Quest Diagnostics Nichols 89 
Institute (San Juan Capistrano, CA, USA), which is part of the Hormone Standardization Program conducted by the 90 
Centers for Disease Control and Prevention. The LC-MS/MS is considered to be the gold standard for measuring 91 
vitamin D status due to its high sensitivity and specificity [4,23]. The analytical measurement range was 19-960 92 
pmol/L and 10-640 nmol/L for 1,25(OH)2D and 25(OH)D, respectively. The coefficient of variation for all analyses 93 
was <10%. The 25(OH)D and 1,25(OH)2D are stable in plasma for more than 10 years when stored under 94 
appropriate conditions as in the present study [24-25]. 95 
 96 
Definition of vitamin D status 97 
 Vitamin D status was defined based on plasma 25(OH)D concentrations. Participants were categorized as 98 
vitamin D deficient (<50 nmol/L), insufficient (50-<75 nmol/L), and sufficient (≥75 nmol/L) according the 99 
Endocrine Society Practice Guidelines [4]. We also used the cutoffs of vitamin D status based on IOM: deficient 100 
(<30 nmol/L), insufficient (30-<50 nmol/L) and sufficient (≥50 nmol/L) [14]. Vitamin D status was also analyzed as 101 
a binary variable according to the Endocrine Society Practice Guidelines as inadequate/adequate (<75/≥75 nmol/L) 102 
[4] and IOM [14] as inadequate/adequate (<50/≥50 nmol/L). 103 
 104 
Covariate assessment 105 
Socioeconomic, demographic, reproductive and lifestyle variables were obtained through interviews with 106 
structured questionnaires administered at the baseline (5–13 weeks of gestation). The following variables were 107 
collected: age (years), self-reported skin color (white/mixed/black), education (years), monthly per capita family 108 
income (R$), parity (nulliparous/parous), first trimester smoking habit (yes/no), first trimester alcohol intake 109 
(yes/no) and leisure physical activity before pregnancy (yes/no). The season was classified according to the date of 110 
recruitment as follows: winter (June 21st to September 21st; spring (September 22nd to December 20th); summer 111 
(December 21st to March 19th); or autumn (March 20th to June 20th).  112 
Gestational age was measured from the first ultrasonography (USG) (n=174) or using the reported date of 113 
the last menstrual period if the first USG was not performed prior to the 24th week of gestation (n=25). Height (cm) 114 
was measured at the beginning of pregnancy using a portable stadiometer (Seca Ltd., Hamburg, Germany). Pre-115 
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gestational body mass index (BMI, weight [kg]/height [m²]) was calculated and categorized (<25/≥25 kg/m²) based 116 
on self-reported pre-gestational weight obtained at the first follow-up visit at the 1st trimester of gestation.  117 
Total vitamin D (IU/day) and calcium (mg/day) intakes were estimated using a semi-quantitative food 118 
frequency questionnaire (FFQ) validated for the adult population of Rio de Janeiro [26]. The questionnaire was 119 
administered in the third trimester and referred to intakes during the prior 6 months. The FFQ included 82 food 120 
items and had eight frequency options: more than three times a day, two to three times a day, once a day, five to six 121 
times a week, two to four times a week, once a week, one to three times a month, and never or hardly ever. Tables of 122 
Nutritional Composition of Food Consumed of Brazilian Institute of Geography and Statistics were used for the 123 
analysis [27]. The FFQ did not take into consideration the use of supplements. Rather, information on vitamin D 124 
supplementation was self-reported in all trimesters.  125 
 126 
Statistical analyses 127 
             The characteristics of the sample were described using mean and standard deviations (SD) for continuous 128 
variables and absolute (n) and relative frequencies (%) for categorical data. 129 
 Baseline characteristics of women with complete 25(OH)D and 1,25(OH)2D information during pregnancy 130 
were compared to those women who presented losses to follow-up with missing information for at least one of 131 
these variables. In addition, baseline characteristics were presented for each variable and stratified according to 132 
25(OH)D status for both the Endocrine Society Practice Guidelines and the IOM criteria. ANOVA was used to 133 
compare means according to 25(OH)D status and the Bonferroni test was employed as the post hoc test. The Chi-134 
squared test was used to compare proportions. 135 
 Pearson coefficient correlations were calculated between 25(OH)D and 1,25(OH)2D in the first, second and 136 
third trimesters. Linear mixed-effects (LME) regression models were performed to evaluate the longitudinal 137 
variation of 25(OH)D and 1,25(OH)2D concentrations during pregnancy. The models included information from all 138 
individuals who had data from at least one time point on 25(OH)D and 1,25(OH)2D concentrations. The LME 139 
models enable the inclusion of time-dependent and time-independent variables and unbalanced time intervals and 140 
the correlation between repeated measures was taken into account [28-29]. Gestational age (weeks) was included in 141 
the LME models as the time variable for both random and fixed effects.  142 
 Interactions between season at recruitment and gestational week were tested when assessing the 143 
longitudinal behavior of 25(OH)D concentrations. We also tested interactions between gestational age and first 144 
trimester vitamin D status to explore the effect on 1,25(OH)2D longitudinal variation. The LME models were 145 
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adjusted for parity, season, education, self-reported skin color and pre-pregnancy BMI based on biological 146 
plausibility and statistical significance (P<0.2) of the associations on the bivariate analysis with the study outcome. 147 
 A P<0.05 was regarded as significant. All analyses were performed in STATA 12.0 (Stata Corporation, 148 
College Station, TX) [30].  149 
 150 
Results 151 
 Losses to follow-up analysis comparing socio-demographic, lifestyle and reproductive characteristics 152 
between women with plasma 25(OH)D and 1,25(OH)2D data in all trimesters and those who had plasma 25(OH)D 153 
data in at least one trimester showed no significant differences (P>0.05) between groups (Data not shown). 154 
 The overall mean 25(OH)D concentrations at the first trimester was 65.0 (17.7 SD) nmol/L which increased 155 
to 78.7 (22.0 SD) nmol/L and 84.1 (24.5 SD) nmol/L during the second and third trimesters, respectively. The mean 156 
of 1,25(OH)2D pmol/L during the first, second and third trimesters were 173.4 (77.9 SD), 227.6 (91.9 SD) and 257.5 157 
(92.3 SD), respectively. The 1,25(OH)2D mean concentrations were significantly different only in the first-trimester 158 
among women within the sufficient category according to Endocrine Society Practice Guidelines. A higher 159 
prevalence of vitamin D deficiency was observed among pregnant women who started the study in winter and spring 160 
compared to those who started in summer and autumn according to both criteria (Table 1).  161 
 The prevalence of pregnant women with plasma 25(OH)D concentrations <75 nmol/L was 70.4%, 41.0% 162 
and 33.9%; the prevalence of women with 25(OH)D concentrations <50 nmol/L was 16.1%, 11.2% and 10.2%; 163 
while 2%, 0% and 0.6%, of women had 25(OH)D concentrations <30 nmol/L at the first, second and third trimester, 164 
respectively (Figure 1). 165 
 Plasma 25(OH)D and 1,25(OH)2D concentrations were weakly but significantly correlated only in the first 166 
trimester of pregnancy (Online Resource Fig. 2a, b, c). The concentrations of 25(OH)D and 1,25(OH)2D 167 
significantly increased throughout gestation in the unadjusted model (β=0.869; 95% CI=0.723-1.014; P<0.001 and 168 
β=3.878; 95% CI=3.136-4.620; P<0.001, respectively) (Fig. 2a, b). Women who started the study during the 169 
summer or autumn seasons had higher mean 25(OH)D concentrations during the first trimester compared to women 170 
whose pregnancy began during winter or spring (Fig. 3). The longitudinal change in concentrations of 25(OH)D 171 
during pregnancy were modified by the season at recruitment in the adjusted model. Women that started the study in 172 
winter (P<0.001), spring (P<0.001) or autumn (P=0.028) presented a longitudinal increase in 25(OH)D 173 
concentrations, while women that started during summer did not (Fig. 4 and Online Resource Table 1).  174 
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Different patterns of 1,25(OH)2D concentrations during the course of gestation were also observed 175 
according to vitamin D status at baseline considering the cutoffs proposed by the Endocrine Society Practice 176 
Guidelines. Women with insufficient concentrations of vitamin D at baseline had greater longitudinal increases in 177 
1,25(OH)2D in comparison to women with sufficiency in the adjusted model (P=0.006), but not among women with 178 
deficient 25(OH)D concentrations (P=0.364) (Fig. 5 and Online Resource Table 1). We did not observe 179 
interactions between vitamin D status at baseline according to IOM and 1,25(OH)2D concentrations during 180 
pregnancy (data not shown). 181 
 182 
Discussion 183 
 The present study has three main findings. First, it was observed that the prevalence of vitamin D 184 
inadequacy varied significantly according to the adopted criteria. The prevalence of vitamin D inadequacy was high, 185 
especially in the first trimester using the Endocrine Society Practice Guidelines (<75 nmol/L). It was moderate when 186 
the inadequacy criterion from the IOM (<50 nmol/L) was considered, but virtually non-existent when the IOM 187 
deficiency criterion was employed (<30 nmol/L). Second, it was observed that the longitudinal patterns of 25(OH)D 188 
concentrations during pregnancy were modified by the season at recruitment. Finally, when we stratified the 189 
participants according to vitamin D status at baseline, pregnant women who had vitamin D insufficiency (50-<75 190 
nmol/L) had a greater increase in 1,25(OH)2D concentrations throughout pregnancy compared to women with 191 
25(OH)D adequacy (≥75 nmol/L). 192 
There is no consensus for the definition of vitamin D inadequacy for pregnant women and results should be 193 
interpreted cautiously. We used the cut-off values proposed by the Endocrine Society Practice Guidelines [4] and 194 
the IOM [14] to allow comparisons among studies. Our results revealed that the prevalence of 25(OH)D <75 195 
nmol/L, <50 nmol/L and <30 nmol/L at the first trimester was 70.4%, 16.1% and 2.1%, respectively. Studies with 196 
pregnant women that have used the 25(OH)D cut points of <75 nmol/L also found a high prevalence of vitamin D 197 
inadequacy in countries such as Korea (91.4%) [31], Spain (64.1%) [32], the United States (54.4%) [33], and other 198 
sunny regions such as Thailand (75.5%) [7], and Australia (80.4%) [6]. Results from a systematic review and meta-199 
analysis revealed that the prevalence of 25(OH)D <50 nmol/L during pregnancy was greater in regions such as the 200 
Americas (64%), Europe (57%), Eastern Mediterranean (46%), South-East Asian (87%) and Western Pacific 201 
countries (83%), in comparison to the present study [34]. In contrast, it is worth noting that only 2% of women in 202 
this cohort presented 25(OH)D concentrations <30 nmol/L, a more restrictive cut-off point that classifies vitamin D 203 
deficiency according to the IOM criteria. A higher prevalence of 25(OH)D <30 nmol/L have been reported in 204 
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countries such as Australia (15%), Belgium (12%), the Netherlands (23%) and India (60%) [2]. Kiely et al. (2016) 205 
[35] observed in a large cohort from Ireland that 17% of the pregnant women had 25(OH)D <30 nmol/L, while 206 
Haggarty et al. (2013) [36] observed in a cohort study from Scotland that 21.5% had 25(OH)D values <25 nmol/L. 207 
The mean 25(OH)D concentration observed in our study (65.0 nmol/L)  in early pregnancy is higher than other 208 
larger cohorts with pregnant women from countries located at higher altitudes such as Ireland (56.7 nmol/L) and 209 
Scotland (40.2 nmol/L) [35,36], but is comparable to other studies in sunny regions [2,6,7].  210 
We found only one study comprising healthy pregnant women in Brazil that has addressed a vitamin D 211 
research question. This study was a clinical trial with 26 pregnant adolescents in the placebo group and 30 in the 212 
supplemented group (calcium and vitamin D) and found plasma 25(OH)D concentrations of 57.9 (20.7 SD) nmol/L 213 
and 59.5 (20.6 SD) nmol/L, respectively at baseline (second trimester of gestation) [37]. For the same period of 214 
gestation those concentrations were lower than the observed in our sample [78.7 (22.0 SD) nmol/L]. 215 
Some other factors could explain the higher prevalence of vitamin D inadequacy observed in this cohort, 216 
Air pollution has been inversely associated with 25(OH)D concentration [5]. Air pollution is known to absorb 217 
ultraviolet B (UVB) rays and thereby limit cutaneous synthesis of vitamin D [5,38). Rio de Janeiro is known to have 218 
high pollution with particulate matter less than 10 μm in diameter (PM10) estimated to be 67 µg/m3 in 2010 [39]. 219 
This value is above the World Health Organization recommendations (<20 µg/m3 annual average concentrations) 220 
[40]. We hypothesize that air pollution in Rio de Janeiro plays a role in the observed high prevalence of vitamin D 221 
inadequacy in this cohort.  222 
We found a mean vitamin D intake of only 186.8 IU/day, which is well below the recommendations set 223 
forth for pregnant women by both the Endocrine Society Practice Guidelines (1500 - 2000 IU/day) [4] and the IOM 224 
(600 IU/day)[14]. Inadequate dietary intake during pregnancy has been observed in other countries such as the 225 
United States [41], Iran [5] and Thailand [42]. Few food items naturally contain vitamin D in the Brazilian diet. 226 
Also, there is no national mandatory food fortification or supplementation program for vitamin D [23]. The mean 227 
calcium intake (760.2 mg/day) was also below the IOM recommendation (1,000 mg/day) for pregnant women. 228 
Similar results of low vitamin D and calcium intake were also observed in a systematic review and meta-analysis 229 
during pregnancy in regions such as the United States, Europe and Australia [43]. Finally, none of the women from 230 
our sample reported vitamin D and calcium supplementation during pregnancy. In Brazil, vitamin D and calcium 231 
supplementation are not usual among women receiving pre-natal care in public service [44]. 232 
Brazil is a racially diverse country, resulting in a mixed skin pigmentation of the population, which can 233 
affect endogenous production of vitamin D via sun exposure [18,45]. In the current study, 26.7% self-reported to be 234 
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blacks and 46.2% mixed. Low vitamin D status has been found among obese adults, because vitamin D can be 235 
partially sequestered by body fat [46]. However, we did not find associations between vitamin D status with vitamin 236 
D and calcium intake, skin pigmentation, or pre-pregnancy BMI.  237 
Physiological adjustment of vitamin D metabolism occurs during pregnancy. The activity of the 1α-238 
hydroxylase enzyme is increased in the kidney, placenta and decidua [47-48], and an elevation in plasma vitamin D-239 
binding protein (DBP) is observed [19]. The kidney has megalin which internalizes 25(OH)D-DBP resulting in the 240 
release of 25(OH)D for its conversion to 1,25(OH)2D [19,49]. Moreover, the expression of vitamin D receptor 241 
(VDR) may be increased in the placenta and decidua during pregnancy [50]. These changes are important for the 242 
maternal and fetal requirements of 1,25(OH)2D during this period [4]. 243 
Few prospective studies have previously measured longitudinal changes in vitamin D concentrations in 244 
pregnant women. During this period an increase in 1,25(OH)2D is well reported while changes in 25(OH)D 245 
concentrations remain controversial [20-22]. Lee et al. [22] evaluated a sample of 275 Korean pregnant women and 246 
found that the mean 25(OH)D concentration during the first trimester was significantly lower than in the second and 247 
third trimesters, even after adjusting for season. Lundqvist et al. [51] reported that 25(OH)D concentrations 248 
increased slightly over the duration of pregnancy in 184 Swedish women. However, when the authors considered the 249 
months of recruitment, a lower rise of 25(OH)D concentrations during pregnancy was observed between women that 250 
started the study in summer, and a peak-shaped pattern during winter. On the other hand, Zhang et al. [21] evaluated 251 
30 Irish women at several pregnancy weeks (15, 20, 24, 28, 32, 36 and 40) and reported that 25(OH)D 252 
concentrations decreased during this period. However, these women were recruited only during summer. Fernandez-253 
Alonso et al. [52] also observed a decrease in 25(OH)D concentrations from first to third trimester in 148 Spanish 254 
pregnant women considering the effect of season. We found that women who started the study during spring, winter 255 
and autumn increased 25(OH)D concentration over this period. The women that began the study during summer had 256 
high 25(OH)D concentrations, and thus presented no change during pregnancy.  257 
 The increase of 1,25 (OH)2D can be probable attributed to an increase on the metabolism of 25(OH)D and 258 
thus, resulting in the decreased in the 25(OH)D [19,49,53]. However, we suggest that the elevation of DBP [19] 259 
during pregnancy could prolong the 25(OH)D half-life during this period as a form of protection [53-54]. Thus, 260 
besides the influence of season women that begin the study with higher or lower concentrations of 25(OH)D can 261 
maintain or increase this metabolite during pregnancy, respectively [53-54]. 262 
Brazil is a tropical country with abundant sunlight and the State of Rio de Janeiro, situated at approximately 263 
23ºS latitude, favors conditions for cutaneous vitamin D production. The ultraviolet B radiation is high throughout 264 
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the year and reaches maximum values in summer [23,55]. Therefore, high concentrations of 25(OH)D are expected 265 
between women who started the study during summer is plausible, even in a sunny region, as has been reported in 266 
other studies [15,42]. Furthermore, in the summer, people are more exposed to the sunlight, and do more outdoor 267 
leisure activities, such as going to the beach, which, besides being a cultural habit, is also accessible to the low-268 
income population. The seasonal variation of vitamin D is even greater in regions with higher latitudes and well-269 
defined seasons, as for example in pregnant woman resident in European countries as Ireland (52°N) or Spain 270 
(40°N), with lower concentrations of vitamin D in winter [21,52,56].  271 
In a systematic review and meta-analysis involving twenty studies, the authors found that serum 272 
1,25(OH)2D was not related with 25(OH)D in pregnant women at term, and that the 25(OH)D concentrations were 273 
not different from the concentrations found in non-pregnant women, though the 1,25(OH)2D concentrations were 274 
twice as high than the non-pregnant women [20]. Nevertheless, this study considered pregnant women at term and 275 
was comprised of cross-sectional data only. Hollis et al. (2011) [41] in a randomized controlled trial with vitamin D 276 
supplementation found an association between circulating 1,25(OH)2D concentrations and circulating 25(OH)D in 277 
148 pregnant women evaluated at 12, 16, 20, 24, 28, 32 and 36 weeks. However, concentrations of 25(OH)D of at 278 
least 100 nmol/L were needed to enable a maximum 1,25(OH)2D increase during this period. Young et al. (2012) 279 
[57] observed that 25(OH)D measured at mid-gestation (∼26 weeks) was inversely associated with 1,25(OH)2D at 280 
delivery in a sample with 168 pregnant adolescents. 281 
In the present study, we did not find a longitudinal association between 25(OH)D and 1,25(OH)2D.We 282 
observed that pregnant women with vitamin D insufficiency at baseline according to Endocrine Society Practice 283 
Guidelines had a greater increase in 1,25(OH)2D concentrations throughout pregnancy when compared to women 284 
with sufficient 25(OH)D concentrations. These results indicate that there is a possible mechanism to meet the 285 
additional demands of vitamin D among pregnant women with low concentrations of 25(OH)D in early pregnancy. 286 
This may be due to secondary hyperparathyroidism associated with low plasma 25(OH)D, thereby increasing the 287 
renal production of 1,25(OH)2D [3-4]. Another possible mechanism is that there are four different 1α-hydroxylase 288 
enzymes with distinct concentrations of regulation, one of which sufficiently converts even small amounts of 289 
vitamin D efficiently to 25(OH)D [58-59]. Moreover, considering that there is an increased activity of 1α-290 
hydroxylase enzyme [47-48], DBP concentrations [19] and VDR expression during gestation [50], we suggest that 291 
these changes are more pronounced among pregnant women with 25(OH)D inadequacy. This may be a form of 292 
protection to prevent further reductions in the 25(OH)D concentration during the course of pregnancy. We believe 293 
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that with a larger sample size this pattern would have also occurred in women with vitamin D insufficiency at 294 
baseline according to cut points by IOM. 295 
The current study has some limitations. First, information on individual sun exposure was not collected. 296 
Instead, we considered the season at recruitment. Second, the loss to follow up was 14.6% and 13.5% for 25(OH)D 297 
and 1,25(OH)2D, respectively. Despite the losses to follow-up, we did not identify significant differences in socio-298 
demographic, lifestyle and reproductive characteristics between pregnant women with vitamin D data in all 299 
trimesters or those with data in at least one trimester. Other limitation of this study is the lack of assessment of 300 
serum PTH, calcium, phosphorus and DBP. On the other hand, this cohort study has important strengths. Plasma 301 
1,25(OH)2D and 25(OH)D concentrations were evaluated in each of the three pregnancy trimesters, and when 302 
performing the longitudinal models, our analyses were adjusted for several important confounders. 25(OH)D and 303 
1,25(OH)2D were also analyzed by the gold standard method (LC-MS/MS).  304 
Low concentrations of vitamin D during pregnancy may be associated with increased risk of adverse 305 
maternal outcomes as gestational diabetes mellitus and low birth weight [5,8]. Further, there is a high correlation 306 
between maternal and fetal cord blood 25(OH)D concentrations [34]. Studies have suggested that low vitamin D 307 
status during pregnancy is associated with short and long-term newborn health consequences [5,8,60-61]. According 308 
to the theory of developmental origins of diseases (fetal programming), nutrition allows early life adaptation when 309 
there is an adverse environment. Thus, low concentrations of vitamin D during pregnancy can have effects 310 
throughout life via fetal programming [62], as for example negative impact in brain health, inflammation and 311 
respiratory disorders [61,63-64]. 312 
The prevalence of vitamin D inadequacy was high throughout pregnancy. Our results indicate that there is a 313 
need to examine the vitamin D status of pregnant women residing in other areas of Brazil who may have less sun 314 
exposure. There were different patterns of longitudinal 25(OH)D concentrations according to the season at 315 
recruitment. Although an increase in 1,25(OH)2D was observed, these changes were not sufficient to reach vitamin 316 
D sufficiency in a high proportion of women at the level of the current recommendations for adults. Pregnant 317 
women who had insufficient 25(OH)D at the beginning of pregnancy had a higher increase in 1,25(OH)2D across 318 
trimesters than those women with sufficient baseline 25(OH)D concentrations, after controlling for important 319 
confounders. The findings from this prospective cohort conducted in apparently healthy women from a tropical and 320 
sunny region contributes to the understanding of 25(OH)D and 1,25(OH)2D changes during pregnancy and 321 
highlights the importance of vitamin D sufficiency in early pregnancy. Our study has the potential for generating 322 
new evidence since there are few studies that prospectively evaluated plasma 1,25(OH)2D and 25(OH)D 323 
13 
 
  
concentrations in healthy pregnant women. Further studies are necessary to set the appropriate 25(OH)D cut points 324 
to compensate for the increased physiological requirements of vitamin D during pregnancy 325 
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Table 1. Baseline characteristics according to vitamin D status in women followed at a public health center in Rio de Janeiro, Brazil, 2009-2012. 
 
Notes: *P-value refers to ANOVA test or to chi-squared test. 
a, b, c Different letters at the same line indicate statistically significant difference (P<0.05) between categories of vitamin D using Bonferroni post hoc test. 25(OH)D=25-hydroxyvitamin D; 
1,25(OH)2D=1,25-dihydroxyvitamin D; BMI=Body Mass Index.  
22 
 
  
 
 
Fig. 1 Frequency of vitamin D status according to trimester of pregnancy in women followed at a public 
health center in Rio de Janeiro, Brazil, 2009-2012.  
 
Notes: a Vitamin D status according to the Endocrine Society Practice Guidelines, vitamin D inadequacy 
refers to the sum of vitamin D deficient and insufficient (25(OH)D <75 nmol/L). b Vitamin D status 
according the Institute of Medicine, vitamin D  inadequacy refers to the sum of vitamin D deficient and 
insufficient (25(OH)D <50 nmol/L). 
23 
 
  
 
 
Fig. 2 Changes in plasma 25(OH)D and 1,25(OH)2D concentrations during pregnancy in women followed at a public health center in Rio de Janeiro, Brazil, 2009-2012. 
 
Notes: a Fitted values were predicted using an unadjusted longitudinal linear regression model between 25(OH)D concentration (nmol/L) and gestational age (weeks) (n=225 
groups, n=565 observations). b Fitted values were predicted using an unadjusted longitudinal linear regression model between 1,25(OH)2D concentration (pmol/L) and 
gestational age (weeks) (n=214 groups, n=522 observations). CI=confidence interval; 25(OH)D=25-hydroxyvitamin D; 1,25(OH)2D=1,25-dihydroxyvitamin D. The group 
refers to the number of women with at least one data point in time and observation refers to the total number of data points in time for all women. 
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Fig. 3 Mean in plasma 25(OH)D concentration according to first, second and third trimester of pregnancy and season of recruitment into the study among women followed at 
a public health center in Rio de Janeiro, Brazil, 2009-2012. 
 
 Notes: Results are presented as mean and standard deviation (error bars); winter=June 21st to September 21st; spring=September 22nd to December 20th; summer=December 
21st to March 19th; autumn=March 20th to June 20th; 25(OH)D=25-hydroxyvitamin D. 
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Fig. 4 Changes in plasma 25(OH)D concentration during pregnancy according to seasons at recruitment in women followed at a public health center in Rio de Janeiro, Brazil, 
2009-2012. 
Notes: Interaction between season at first trimester and gestational age: summer (n=42: reference); winter (n=51): β=1.441; 95% CI, 1.066 to 1.816, P<0.001; spring (n=54): 
β=1.126; 95% CI, 0.758 to 1.493, P<0.001; autumn (n=52): β=0.398; 95% CI, 0.044 to 0.752, P=0.028. Longitudinal model adjusted for parity, education, self-reported skin 
color and pre-pregnancy Body Mass Index. The shaded grey area represents the 95% CI. The black lines at the bottom of the figure represent the scatter of the data. 
winter=June 21st to September 21st; spring=September 22nd to December 20th; summer=December 21st to March 19th; autumn=March 20th to June 20th. 25(OH)D=25-
hydroxyvitamin D; 1,25(OH)2D=1,25-dihydroxyvitamin D; β=Longitudinal Linear Regression Coefficient; CI=Confidence Interval. 
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Fig. 5 Changes in plasma 1,25(OH)2D concentration during pregnancy according to vitamin D status at baseline in women followed at a public health center in Rio de Janeiro, 
Brazil, 2009-2012.  
Notes: Interaction between vitamin D insufficiency (50-<75 nmol/L) (n= 97) and gestational age: β=2.365; 95% CI, 0.675 to 4.054; P=0.006. Longitudinal model adjusted for 
seasons at recruitment, parity, education, self-reported skin color and pre-pregnancy Body Mass Index. The shaded grey area represents the 95% confidence interval. The 
black lines at the bottom of the figure represent the scatter of the data. 1,25(OH)2D=1,25-dihydroxyvitamin D; β=longitudinal linear regression coefficient, CI=Confidence 
Interval.  
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Online Supporting Material 
 
 
 
 
Online Resource Fig. 1 Flowchart of the selection process of study final sample of pregnant woman 
followed at a public health center in Rio de Janeiro, Brazil, 2009-2012.  
 
Notes: a 25(OH)D, total number of observations (data)=565 and  total number of groups (women=225). b 
1,25(OH)2D, total number of observations=522 and total number of groups=214. All women with 
information for 1,25(OH)2D also present data from 25(OH)D concentrations. 25(OH)D=25-
hydroxyvitamin D; 1,25(OH)2D=1,25-dihydroxyvitamin D. The group refers to the number of women 
with at least one data point in time and observations refers to the total number of data points in time for 
all women. 
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Online Resource Fig. 2 Correlation between 1,25(OH)2D and 25(OH)D concentrations during first (a), second (b), and third (c) trimester in women followed at a public 
health center in Rio de Janeiro, Brazil, 2009-2012. 
 
Notes: a first trimester (n=178), b second trimester (n=177), c third trimester (n=167). 25(OH)D=25-hydroxyvitamin D; 1,25(OH)2D=1,25-dihydroxyvitamin D.   
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Online Resource Table 1. Confounders estimates in the longitudinal model of plasma 25(OH)D and 1,25(OH)2D concentrations during pregnancy in women 
followed at a public health center in Rio de Janeiro, Brazil, 2009-2012. 
 
Notes: Longitudinal linear regression coefficient (β), 95% confidence interval (CI) and P were calculated using linear mixed effects; winter=June 21st to September 21st; 
spring=September 22nd to December 20th; summer=December 21st to March 19th; autumn=March 20th to June 20th.; 25(OH)D=25-hydroxyvitamin D;1,25(OH)2D=1,25-
dihydroxyvitamin D; BMI=Body Mass Index. 
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Variables 
 
Total 
n=199 
Vitamin D status at baseline  
Endocrine Society Practice Guidelines 
P-value* 
  Institute of Medicine  
P-value* Deficient 
< 50 nmol/L 
n=32 
Insufficient 
50-<75 nmol/L 
n=108 
Sufficient 
≥ 75 nmol/L 
n=59 
Deficient 
< 30 nmol/L 
n=4 
Insufficient 
30-<50 
nmol/L 
n=28 
Sufficient 
≥ 50 nmol/ 
n=167 
 Mean (SD) 
25(OH)D (nmol/L)           
        First trimester  65.0 (17.7) 39.6 (8.0) a  61.2 (6.7) b 85.8 (11.3) c <0.001 22.5 (6.1) a 42.1 (4.5) b 69.9 (14.6) c <0.001 
        Second trimester  78.7 (22.0) 61.3 (17.6) a   76.2 (19.3) b 94.9 (18.7) c <0.001 35.0 (2.5) a 64.8 (15.8) b 82.6 (21.0) c <0.001 
       Third trimester 84.1 (24.5) 70.5 (20.9) a 81.1 (25.0) a 96.1 (22.3) b <0.001 40.0 (3.5) a 73.5 (19.4) a 86.3 (25.1) b 0.004 
1,25(OH)2D (pmol/L)           
       First trimester  173.4 (77.9) 160.4 (65.1) a 158.9 (73.6) a 203.7 (82.5) b 0.001 115.2 (79.2) 
 
166.8 (62.4) 175.4 (79.8) 0.384 
       Second trimester  227.6 (91.9) 229.1 (97.5) 224.7 (93.1) 221.3 (88.3) 0.948 231.2 (50.7) 228.8 (104.3) 223.5 (91.2) 0.965 
       Third trimester 257.5 (92.3) 241.2 (111.5) 267.7 (90.7) 260.4 (72.9) 0.512 180.0 (115.3) 265.2 (84.8) 226.9 (112.1) 0.328 
Age (years)  26.6 (5.5) 26.8 (5.6) 26.7 (5.5) 26.3 (5.5) 0.876 28.5 (8.1) 26.6 (5.3) 26.6 (5.5) 0.795 
Per-capita family income 
(R$)  
538.7 (328.8) 599.5 (403.9) 506.3 (314.7) 495.8 (295.2) 0.452 741.5 (326.7) 578.5 (415.2) 527.0 (312.4) 0.348 
Dietary vitamin D intake 
during pregnancy (IU/day)  
186.8 (109.9) 169.6 (91.7) 187.4 (108.8) 196.4 (122.7) 0.607 241.3 (139.4) 161.3 (84.8) 190.4 (113.2) 0.320 
Dietary calcium intake 
during pregnancy (mg/day)  
774.5 (361.1) 748.5 (313.3) 760.3 (366.0) 819.5 (382.5) 0.589 752.4 (504.3) 748.0 (299.3) 780.2 (371.2) 0.912 
n (%) 
Table
Vitamin D supplementation 
during gestation
 
 
 
gestation
 b
 
    1.000    1.000 
        No  199 (100) 32 (100) 108 (100) 75 (100)  4 (100) 28 (100) 167 (100)  
       Yes  0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)  0 (0.0) 0 (0.0) 0 (0.0)  
Calcium supplementation 
during gestation
 
 
    1.000    1.000 
        No  199 (100.0) 32 (100.0) 108 (100.0) 59 (100.0)  4 (100.0) 28 (100.0) 167 (100.0)  
       Yes  0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)  0 (0.0) 0 (0.0) 0 (0.0)  
Season at recruitment     <0.001    0.010 
       Winter 51 (25.6) 15 (46.9) 30 (27.8) 6 (10.2)  2 (50.0) 13 (46.4) 36 (21.6)  
       Spring 54 (27.2) 12 (37.5) 29 (26.9) 13 (22.0)  2 (50.0) 10 (35.7) 
 
42 (25.1)  
       Summer 42 (21.1) 2 (6.2) 21 (19.4) 19 (32.2)  0 (0.0) 2 (7.2) 40 (24.0)  
       Autumn 52 (26.1) 3 (9.4) 28 (25.9) 21 (35.6)  0 (0.0) 3 (10.7) 49 (29.3)  
Pre-pregnancy BMI 
(kg/m2)
 b
 
 
     
0.900 
    
0.872 
     <25 119 (59.80) 18 (56.2) 65 (60.2) 36 (61.0)  2 (50.0) 16 (57.1) 101 (60.5)  
      ≥25 80 (40.20) 14 (43.8) 43 (39.8) 23 (39.0)  2 (50.0) 12 (42.9) 66 (39.5)  
Alcohol consumption      0.224    0.203 
       No  158 (79.4) 29 (90.6) 84 (77.7) 45 (76.3)  0 (0.0) 3 (10.7) 38 (22.8)  
       Yes  41 (20.6) 3 (9.4) 24 (22.3) 14 (23.7)  4 (100.0) 25 (89.3) 129 (77.2)  
Smoking habit      0.687    0.671 
       No  186 (93.5) 31 (96.9) 100 (92.6) 55 (93.2)  4 (100.0) 27 (96.4) 155 (92.8)  
       Yes 13 (6.5) 1 (3.1) 8 (7.4) 4 (6.8)  0 (0.0) 1 (3.6) 12 (7.2)  
Education (years)      0.207    0.207 
       <8 60 (30.2) 8 (25.0) 29 (26.8) 23 (39.0)  9 (25.0) 29 (26.9) 33 (39.0)  
       ≥8 
 
 
 
 
139 (69.8) 24 (75.0) 79 (73.2) 36 (61.0)  24 (75.0) 79 (73.1) 36 (61.0)  
Self-reported skin color      0.268    0.306 
        White  54 (27.1) 4 (12.5) 35 (32.4) 15 (25.4)  0 (0.0) 4 (14.3) 50 (29.9)  
       Mixed  92 (46.2) 18 (56.2) 47 (43.5) 27 (45.8)  3 (75.0) 15 (53.6) 74 (44.3)  
       Black 53 (26.7) 
 
10 (31.3) 26 (24.1) 17 (28.8)  1 (25.0) 9 (32.1) 43 (25.8)  
Leisure physical activity 
before pregnancy  
    0.213    0.342 
       No 148 (75.1) 26 (83.9) 82 (76.6) 40 (67.8)  4 (100.0) 22 (81.5) 122 (73.5)  
       Yes 49 (24.9) 5 (16.1) 25 (23.4) 19 (32.2)  0 (0.0) 5 (18.5) 44 (26.5)  
Parity      0.322    0.393 
     Nulliparous 
 
78 (39.2) 16 (50.0) 42 (38.9) 20 (33.9)  2 (50.0) 14 (50.0) 62 (37.1)  
     Parous 121 (60.8) 16 (50.0) 66 (61.1) 39 (66.1)  2 (50.0) 14 (50.0) 105 (62.9)  
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